PAHFKB:一个知识库,以支持个性化的运动处方建议,以预防和干预心力衰竭
Ke Zhang1,2, Shumin Ren1,2, Ting Bao2,3
1Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
这项研究开发了PAHFKB,这是针对心力衰竭 (HF) 个性化运动处方的知识库. PAHFKB组织体育活动 (PA) 数据,以改善HF管理和数字健康干预.
科学领域:
- 心脏病学 心脏病学
- 数字健康数字健康
- 运动生理学 运动生理学
背景情况:
- 目前的运动指南缺乏针对心力衰竭 (HF) 等复杂疾病的个性化.
- 个性化的运动处方 (EP) 对于有效的高压管理至关重要.
- 需要一个基于知识的系统来整合体力活动 (PA) 和高频数据.
研究的目的:
- 开发PAHFKB (身体活动-心力衰竭知识库),用于HF个性化EP的系统.
- 挖掘,分析和组织有关PA和HF的现有文献和数据.
- 为个性化PAHF建立数据标准,并在数字健康领域推进AI.
主要方法:
- 从PubMed.收集了关于PA和HF的3186个引用.
- 使用实体关系模型定义的数据标准.
- 使用MySQL和ASP.NET开发PAHFKB,集成证据,EP和可视化工具.
主要成果:
- PAHFKB纳入了357项研究 (1989-2021),来自43个国家的90多万名受试者.
- 提取了1010个PAHF项目,包括357个练习方案,333个结果和42个风险因素.
- 最常见的方案是每周3次60分钟的中等强度有氧运动.
结论:
- PAHFKB通过各种工具和可视化支持个性化EP用于HF管理.
- 该系统促进了个性化的决策支持,数据标准和数字健康中的可解释AI.
- PAHFKB旨在加强临床实践和数字治疗,以预防和干预HF.
更多相关视频
07:26Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans
Published on: October 17, 2018
08:27A Real-World High-Intensity Interval Training Protocol for Cardiorespiratory Fitness Improvement
Published on: February 22, 2022
相关概念视频
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be...
Heart Failure Drugs: β-Blockers
Pathophysiology of Heart Failure
Exercise and Muscle Performance
Endurance exercises
Endurance exercises involve running, swimming, or cycling, which require repetitive movements with low force output. When a person engages in endurance exercise, a few noticeable changes occur in their skeletal muscles. For instance, the number of capillaries...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
